Like books and minds, a public health response in the midst of the steadily worsening novel coronavirus pandemic works best when it is open. 

It’s been almost a week since the Indian Council of Medical Research (ICMR), the apex biomedical body on Covid-19 management, approved test kits from private manufacturers to supply real-time . Meaningful testing, though, has still not happened. Many of the private labs that were approved subsequently didn’t begin testing until Saturday, 28 March.


Seema Singh

Seema has over two decades of experience in journalism. Before starting The Ken, Seema wrote “Myth Breaker: Kiran Mazumdar-Shaw and the Story of Indian Biotech”, published by HarperCollins in May 2016. Prior to that, she was a senior editor and bureau chief for Bangalore with Forbes India, and before that she wrote for Mint. Seema has written for numerous international publications like IEEE-Spectrum, New Scientist, Cell and Newsweek. Seema is a Knight Science Journalism Fellow from the Massachusetts Institute of Technology and a MacArthur Foundation Research Grantee.

View Full Profile

Sign up to our India edition to read this story instantly

To sign up, you’ll create an account that will give you access to a new free story published once a week and archive of 214+ previously published free stories from our India edition. You’ll also receive one email every morning from us introducing the day’s story.

If you’ve already signed up, just enter your email below or login using Facebook or Google.